U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 213907

DAPSONE (DAPSONE)
5%
Marketing Status: Prescription
Active Ingredient: DAPSONE
Proprietary Name: DAPSONE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213907
Product Number: 001
Approval Date: Jun 6, 2023
Applicant Holder Full Name: BELOTECA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top